Consequences of oral antithrombotic use in patients with chronic kidney disease
Abstract We assessed the risks of bleeding, acute kidney injury (AKI), and kidney failure associated with the prescription of antithrombotic agents (oral anticoagulants and/or antiplatelet agents) in patients with moderate‐to‐advanced chronic kidney disease (CKD). CKD‐REIN is a prospective cohort of...
Guardado en:
Autores principales: | Solène M. Laville, Oriane Lambert, Aghiles Hamroun, Marie Metzger, Christian Jacquelinet, Maurice Laville, Luc Frimat, Denis Fouque, Christian Combe, Carole Ayav, Roberto Pecoits‐Filho, Bénédicte Stengel, Ziad A. Massy, Sophie Liabeuf, the CKD‐REIN Study Collaborators |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/496f063a74864d888537bfc7d12c9f05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotic Therapy after Venous Stent Placement
por: Nicholas Xiao, et al.
Publicado: (2020) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
por: Iosif Xenogiannis, et al.
Publicado: (2021) -
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Tamara García Camarero, et al.
Publicado: (2020) -
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Leslie Marisol Lugo, et al.
Publicado: (2020) -
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021)